Nine de Graaf

472 citations
11 papers · 85 indexed · h-index 4
Topics
Pancreatic and Hepatic Oncology Research (8 papers)Gallbladder and Bile Duct Disorders (7 papers)Pancreatitis Pathology and Treatment (4 papers)

In The Last Decade

Nine de Graaf

8 papers receiving 82 citations

Peers

Nine de Graaf
Comparison fields: 5 of 34
  • Oncology 48
  • Pulmonary and Respiratory Medicine 29
  • Surgery 27
  • Rheumatology 21
  • Epidemiology 17
Replace Damir Muhvić with:
Damir Muhvić Croatia
P. Novoa Argentina
Hannah L. Tattersall United Kingdom
Filipe Seixo Portugal
Beatrice Bianchi Italy
K Kim South Korea
Toshiichi Watanabe Japan
Kavi Fatania United Kingdom
Manuel L. R. Tjin‐A‐Ton Netherlands
Sasan Mirfakhraee United States
Nine de Graaf relative to Damir Muhvić Croatia Damir Muhvić's profile →
Citations per field
00.5×10×15×19×
Damir Muhvić · 1×
Citations per year

Countries citing papers authored by Nine de Graaf

Since Specialization
Citations

This map shows the geographic impact of Nine de Graaf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nine de Graaf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nine de Graaf more than expected).

Fields of papers citing papers by Nine de Graaf

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nine de Graaf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nine de Graaf. The network helps show where Nine de Graaf may publish in the future.

Co-authorship network of co-authors of Nine de Graaf

This figure shows the co-authorship network connecting the top 25 collaborators of Nine de Graaf. A scholar is included among the top collaborators of Nine de Graaf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nine de Graaf. Nine de Graaf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
#WorkIndexed citations
1 0
2 4
3 3
4 1
5 0
6 3
7 6
8 0
9 3
10 34
11 31

About Nine de Graaf

Nine de Graaf is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Neurology, having authored 11 papers that have together received 85 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (8 papers), Gallbladder and Bile Duct Disorders (7 papers) and Pancreatitis Pathology and Treatment (4 papers). The work is most often cited by research in Oncology (48 citations), Rheumatology (21 citations) and Neurology (14 citations). Nine de Graaf has collaborated with scholars based in Netherlands, Italy and United States. Frequent co-authors include Peter M. ten Klooster, Harald E. Vonkeman, Jony van Hilst, Mohammad Abu Hilal, Marc G. Besselink, Giorgio Spatola, Cesare Giorgi, Karol Migliorati, Alberto Franzin and Marco Maria Fontanella. Their work appears in journals such as Annals of Surgery, Journal of the American College of Surgeons and Annals of Surgical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026